Indian J Pharm Close
 

Figure 1: Effects of puerarin treatment in long-term neurological outcomes and brain infarction after focal stroke in rats. (a) Modified neurological severity score was assessed at day 1, day 4, day 7 and day 14 after stroke compared to saline treated control animals. (b) Adhesive-remove test was assessed at day 1, day 4, day 7 and day14 after stroke. (c) Representative H and E stained brain sections for brain infarction determination at 14 days after stroke. (d) Quantitation of brain infarction volume. Data are expressed as mean ± standard deviation. #P < 0.05 for 50 mg/kg of puerarin versus saline, *P < 0.05 for 100 mg/kg of puerarin versus saline. n = 15-18 rats per group

Figure 1: Effects of puerarin treatment in long-term neurological outcomes and brain infarction after focal stroke in rats. (a) Modified neurological severity score was assessed at day 1, day 4, day 7 and day 14 after stroke compared to saline treated control animals. (b) Adhesive-remove test was assessed at day 1, day 4, day 7 and day14 after stroke. (c) Representative H and E stained brain sections for brain infarction determination at 14 days after stroke. (d) Quantitation of brain infarction volume. Data are expressed as mean ± standard deviation. <sup>#</sup><i>P</i> < 0.05 for 50 mg/kg of puerarin versus saline, *<i>P</i> < 0.05 for 100 mg/kg of puerarin versus saline. <i>n</i> = 15-18 rats per group